Cite
MLA Citation
Ahmad A. Tarhini et al.. “Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma.” Melanoma research, vol. 27, no. 4, 2017, p. . http://access.bl.uk/ark:/81055/vdc_100070746314.0x000025